Amy Sullivan - 17 Mar 2023 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Role: Chief Financial Officer
Signature: /s/ Brian Burkavage, Attorney-in-Fact for Amy Sullivan
Issuer symbol: IOBT
Transactions as of: 17 Mar 2023
Net transactions value: +$58,018
Form type: 4
Filing time: 20 Mar 2023, 17:35:52 UTC
Previous filing: 19 Oct 2022
Next filing: 22 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IOBT	Common Stock	Purchase	$58,018	+25,000		$2.32	25,000	17 Mar 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transaction was executed in multiple trades in prices ranging from $2.18 to $2.46, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.

Content

The transaction was executed in multiple trades in prices ranging from $2.18 to $2.46, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each respective price within the range set forth in this footnote.